Improve Precision Medicine Timelines in Community Oncology Care, Upcoming Webinar Hosted by Xtalks

Free June 4, 2026 webinar on streamlining precision oncology in community settings.

TORONTO, May 13, 2026 /PRNewswire/ -- Most oncology strategies are shaped by evidence and infrastructure built and measured in academic centers. Yet most patients are treated in community oncology settings, where biopsy timing, tissue adequacy, turnaround time for molecular results, payer utilization management and social determinants of health (SDOH) have huge impacts on the consistent delivery of precision medicine.

To help improve community-based cancer treatment, Amplity and Xtalks are hosting a multidisciplinary discussion to help healthcare practitioners and life science leaders understand how they can use a community oncology test-to-treat playbook to strengthen biomarker testing, treatment actions and evidence planning at scale.

Noted national oncology experts will explore key real-world factors that shape precision oncology uptake in communities—including payer requirements and referral networks—and how these differ from academic centre models. Panelists will also examine:

• What broader germline testing may mean for diverse community populations when clinically relevant findings appear outside guideline criteria.
• How measurable SDOH factors can affect outcomes among underserved cohorts undergoing advanced genomic testing.
• Decision-making criteria for liquid biopsy implementation.
• Evidence building across diverse patient groups.
• Scalable access strategies to ensure appropriate use of new therapies and diagnostics.

Finally, using case-based examples and published community data, the discussion will illustrate how community practices put "precision medicine basics" into action to help life sciences leaders use clinically grounded insights to develop and deploy more impactful oncology therapeutics, diagnostics and evidence generation strategies.

Register for this webinar to learn how a community oncology test-to-treat playbook can strengthen biomarker testing, treatment action and evidence strategies at scale.

Join Kashyap Patel, MD, CEO, Carolina Blood and Cancer Care Associates; Debra Patt, MD, PhD, MBA, Executive Vice President, Policy and Strategy, Texas Oncology; Susan Duffy, President, Comms, Amplity; and Kristin Siyahian, VP of Branded Channels, Amplity for a live webinar on Thursday, June 4, 2026, at 1:00 p.m. EDT (7:00 p.m. CEST).

For more information, or to register for this event, visit Improve Precision Medicine Timelines in Community Oncology Care.

ABOUT XTALKS

Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks